64Cu-DOTATATE-PET for Lyme Neuroborreliosis
Recruiting
N/A
Interventional Study
Borrelia Burgdorferi Neuroborreliosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 50 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to investigate the applicability and performance of 64Cu-DOTATATE PET/CT/MR for diagnosis in patients with Lyme neuroborreliosis (LNB).
In this prospective, observational cohort study with 64Cu-DOTATATE, the investigators wish to include a total of 50 patients clinically suspected of LNB. The investigators will investigate the diagnostic value of 64Cu-DOTATATE-PET comparin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Age ≥ 18 years AND
* Clinical suspicion of LNB AND
* Must be able to read and understand the patient information and to give informed consent -
Exclusion Criteria:
* Pregnancy OR
* Breast-feeding OR
* Concluded antibiotic treatment OR
* Weight more than the maximum weight lim…
Contacts